Showing results (631-640 of 667) with videos related to
Sort By:
Pageof 67
Cancer Cell|November 14, 2018
PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8<sup>+</sup> T Cell Invigoration and Polyclonal T Cell Expansion in Cancer PatientsAung Naing, Jeffrey R Infante, Kyriakos P Papadopoulos, et al.Blood|August 29, 2018
A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigensZhuting Hu, Annabelle J Anandappa, Jing Sun, et al.Tuberculosis (Edinburgh, Scotland)|March 11, 2018
A multicentre verification study of the QuantiFERON<sup>®</sup>-TB Gold Plus assayE D Pieterman, F G Liqui Lung, A Verbon, et al.Nature Biotechnology|February 9, 2026
Sensitive detection of cancer antigens enabled by user-defined peptide librariesKasidet Manakongtreecheep, Claudia Ctortecka, Luis O Correa-Medero, et al.Nature|July 22, 2021
Phenotype, specificity and avidity of antitumour CD8<sup>+</sup> T cells in melanomaGiacomo Oliveira, Kari Stromhaug, Susan Klaeger, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2025
Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equiRebecca M Legere, Jeannine A Ott, Cristina Poveda, et al.JCO Precision Oncology|July 7, 2022
Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor BenefitRomualdo Barroso-Sousa, Juliet Forman, Katharine Collier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2024
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous CancersKara M Schenk, Julie Stein Deutsch, Sunandana Chandra, et al.Nature|May 4, 2022
Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanomaGiacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanomaKerstin Trunzer, Anna C Pavlick, Lynn Schuchter, et al.Pageof 67